IntroductionSarcoidosis is a systemic granulomatous disease of unknown etiology that most commonly affects the lungs and lymph nodes but can involve nearly any organ. When the central nervous system is affected, a condition known as neurosarcoidosis [1], it often presents with cranial neuropathies [2]. Among its less common but severe complications, acute ischemic stroke can occur due to mechanisms such as granulomatous vasculitis, vascular compression, or systemic hypercoagulability [3]. The overlap of symptoms with other neurological conditions, combined with its rarity, makes diagnosing stroke in neurosarcoidosis particularly challenging. Early identification and targeted treatment are crucial to minimizing long-term disability.